SQI Diagnostics Inc. announced it has signed a revenue-producing agreement with a global biotechnology company to provide assay development and future sample testing and analysis services. This customer has contracted test development to SQI to create an immunogenicity assay utilizing SQI’s multiplexing technology. After completing test development, SQI anticipates it will be engaged to provide contract research services to provide …
Recent Comments